BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 907696)

  • 1. Direct binding studies of 125 I-alpha-bungarotoxin and 3H-quinuclidinyl benzilate interaction with axon plasma membrane fragments. Evidence for nicotinic and muscarinic binding sites.
    Marquis JK; Hilt DC; Mautner HG
    Biochem Biophys Res Commun; 1977 Sep; 78(2):476-82. PubMed ID: 907696
    [No Abstract]   [Full Text] [Related]  

  • 2. Concanavalin A-sepharose affinity chromatography of axon plasma membrane proteins. Heterogeneity of cholinergic binding sites.
    Marquis JK; Hilt DC; Mautner HG
    J Neurochem; 1980 May; 34(5):1071-6. PubMed ID: 7373297
    [No Abstract]   [Full Text] [Related]  

  • 3. Binding of N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4'-3H] quinuclidinyl benzilate to CNS extracts of the cockroach Periplaneta americana.
    Lummis SC; Sattelle DB
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 80(1):75-83. PubMed ID: 2858352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic cholinergic receptors in murine lymphocytes: demonstration by direct binding.
    Gordon MA; Cohen JJ; Wilson IB
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2902-4. PubMed ID: 275860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ganglion cells of chicken retina possess nicotinic rather than muscarinic acetylcholine receptors.
    Morgan IG; Mundy PG
    Neurochem Res; 1982 Mar; 7(3):267-74. PubMed ID: 7110503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the specificity of 125-I-alpha-bungarotoxin binding to axonal membranes.
    Jumblatt JE; Marquis JK; Mautner HG
    J Neurochem; 1981 Aug; 37(2):392-400. PubMed ID: 7264666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The binding of the muscarinic receptor antagonist, [3-3H]quinuclidinyl benzilate, to Torpedo marmorata membrane fragments [proceedings].
    Pickard MR; Strange PG
    Biochem Soc Trans; 1978; 6(1):129-31. PubMed ID: 640140
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for muscarinic cholinergic receptors in dog portal vein: binding of [3H]quinuclidinyl benzilate.
    Taniguchi T; Tsukahara T; Fujiwara M
    Life Sci; 1983 Apr; 32(15):1757-63. PubMed ID: 6835022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of muscarinic cholinergic receptors in the lower esophageal sphincter of the cat: binding of [3H]quinuclidinyl benzilate.
    Rimele TJ; Rogers WA; Gaginella TS
    Gastroenterology; 1979 Dec; 77(6):1225-34. PubMed ID: 499710
    [No Abstract]   [Full Text] [Related]  

  • 10. Nicotine and alpha-bungarotoxin binding to axonal and non-neural tissues.
    Jones SW; Galasso RT; O'Brien RD
    J Neurochem; 1977 Nov; 29(5):803-9. PubMed ID: 591957
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic binding sites in rat hippocampal formation: properties and ontogenesis.
    Ben-Barak J; Dudai Y
    Brain Res; 1979 Apr; 166(2):245-57. PubMed ID: 427590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholinergic muscarinic receptor in synaptosomal membranes. Heterogeneity of binding sites for L-[3H]quinuclidinyl benzilate.
    Aguilar JS; Salas PJ; De Robertis E
    Mol Pharmacol; 1982 Sep; 22(2):304-9. PubMed ID: 7144732
    [No Abstract]   [Full Text] [Related]  

  • 13. Muscarinic receptors on rat isolated colonic epithelial cells. A correlation between inhibition of [3H]quinuclidinyl benzilate binding and alteration in ion transport.
    Zimmerman TW; Binder HJ
    Gastroenterology; 1982 Dec; 83(6):1244-51. PubMed ID: 6127277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand-binding propeties of the muscarinic acetylcholine receptor in mouse neuroblastoma cells.
    Strange PG; Birdsall NJ; Burgen AS
    Biochem J; 1978 Jun; 172(3):495-501. PubMed ID: 567477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]-Quinuclidinyl benzilate binding to muscarinic receptors in rat brain: comparison of results from intact brain slices and homogenates.
    Gilbert RF; Hanley MR; Iversen LL
    Br J Pharmacol; 1979 Mar; 65(3):451-6. PubMed ID: 427318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in affinities of muscarinic acetylcholine receptor antagonists for brain and heart receptors.
    Gibson RE; Rzeszotarski WJ; Eckelman WC; Jagoda EM; Weckstein DJ; Reba RC
    Biochem Pharmacol; 1983 Jun; 32(12):1851-6. PubMed ID: 6882462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties and regional distribution of nicotinic cholinergic receptors in the rat hypothalamus.
    Block GA; Billiar RB
    Brain Res; 1981 May; 212(1):152-8. PubMed ID: 7225853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding characteristics of cholinergic sites in rabbit spermatozoa.
    Young RJ; Laing JC
    Mol Reprod Dev; 1991 Jan; 28(1):55-61. PubMed ID: 1994980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Muscarinic receptor in Drosophila melanogaster demonstrated by binding of [3H]quinuclidinyl benzilate.
    Dudai Y; Ben-Barak J
    FEBS Lett; 1977 Sep; 81(1):134-6. PubMed ID: 409619
    [No Abstract]   [Full Text] [Related]  

  • 20. Characterization of nicotine binding in mouse brain and comparison with the binding of alpha-bungarotoxin and quinuclidinyl benzilate.
    Marks MJ; Collins AC
    Mol Pharmacol; 1982 Nov; 22(3):554-64. PubMed ID: 7155123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.